Analyst Ratings For NASDAQ:ALNA – Allena Pharmaceuticals (NASDAQ:ALNA)
Today, B. Riley initiated coverage on NASDAQ:ALNA – Allena Pharmaceuticals (NASDAQ:ALNA) with a Buy with a price target of $23.50.
Some recent analyst ratings include
- 4/25/2018-B. Riley initiated coverage with a Buy rating.
- 4/2/2018-Roth Capital initiated coverage with a Buy rating.
- 3/28/2018-Wedbush Reiterated Rating of Outperform.
- 11/27/2017-Cowen initiated coverage with a Outperform rating.
- 11/27/2017-Jefferies Group initiated coverage with a Buy rating.
- On 11/6/2017 Bessemer Venture Partners Vii, Major Shareholder, bought 36,000 with an average share price of $14.00 per share and the total transaction amounting to $504,000.00.
- On 11/6/2017 James N Topper, Director, bought 500,000 with an average share price of $14.00 per share and the total transaction amounting to $7,000,000.00.
Recent Trading Activity for NASDAQ:ALNA – Allena Pharmaceuticals (NASDAQ:ALNA)
Shares of NASDAQ:ALNA – Allena Pharmaceuticals closed the previous trading session at 14.02 up +0.09 0.65% with 14.460000038146973 shares trading hands.